Andor Du iXDN camera 13um pixels

Department of Health and Human Services, National Institutes of Health, National Cancer Institute, Office of Acquisitions, 9609 Medical Center Drive, Room 1E626, Bethesda, MD 20892, UNITED STATES. Non-USPS mail such as Fedex, UPS and other private carriers please use Rockville, MD 20850. Description The National Institutes of Health (NIH), National Cancer Institute (NCI), Center for Cancer Research (CCR) Laboratory of Receptor Biology and Gene Expression (LRBGE) intends to procure the Brand name or equal Andor Du Ixon Camera. This is a combined synopsis/solicitation for a commercial item, prepared in accordance with format in FAR 12.6 as supplemented with additional information included in this notice. This announcement constitutes the only solicitation and a separate written solicitation will not be issued. This solicitation: No. N02RC52525-24 includes all applicable provisions and clauses in effect through FAR FAC 2005-78 (December 2014) simplified procedures for commercial items. This acquisition is a 100% small business set-aside. The North American Industry Classification System code is 423410 and the standard business size is 100 employees. Only one award will be made as a result of this solicitation. This will be awarded as a firm fixed price type contract. I. Description of Requirement The NCI/CCR/LRBGE would like to assemble a state of the art microscopy system capable of performing simultaneous two-channel single-molecule tracking. For the further development of the NCI's knowledge about the transcription regulation of the cancer cells dual-color tracking of single molecules will be used to probe the specific and non-specific interactions of transcription factors on the same promoter in living cells. The NCI/CCR/LRBGE Optical Microscopy Core plans to procure an Andor Du Ixon 888 EM CCD camera for the simultaneous single molecule tracking with DNA counterstaining in living cells. This camera will be used to upgrade the existing single molecule tracking system that currently allows tracking of only one color, without counterstaining. Single molecule tracking is a state-of-the art method for the biophysical quantification of the behavior of the transcription factors on their DNA targets. The custom-built system proved to be very efficient in tracking the individual molecules in vivo and the results obtained with this system led to publications in high profile journals. The following salient characteristics apply to the Andor Du iXON Ultra EM CCD Camera: - 30MHz and 20 MHz readout modes (EM channel) - Frame rate maximum of 25.7 fps (full resolution - 1024 x 1024) - Optically Centered Crop Mode offering 697 frames/sec from 128 x 128 ROI - USB 3.0 interface - Data conversion to Electrons or Photons, either Real-Time or Post-Processing - Spurious Noise filter that is either Real-Time or Post-Processing - OptAcquire - Push Button acquisition mode optimization - Direct Data Access via separate CameraLink output - Ring Mode - Up to 16 pre-defined exposure times can be uploaded onto the camera FPGA, facilitating instant exposure switching upon acceptance of external (TTL) or software trigger - - Temperature Compensated' linear and calibrated EM Gain scale - i.e. calibration holds at all selected cooling temperatures - Advanced Photon counting mode - including Real-Time and Post-Acquisition definition of accumulated block size - Hardware (FPGA) generated timestamp with 10 ns accuracy II. Delivery: Contractor shall deliver the item within 60 days after award to: NIH/NCI Bethesda, Maryland 20892. The contractor that receives the award will be provided with the complete mailing address and point of contact. Upon delivery, contractor must notify the NCI Contracting Officer Representative (COR) to schedule installation date and time. III. Installation: Contractor shall install the equipment (new) and have ready to use within seven (7) days after delivery and acceptance. IV. Payment: Payment shall be made after delivery, installation, and successful operation of equipment. Payment authorization requires submission and approval of invoice to the NCI COR and NIH Commercial Accounts. QUOTATIONS ARE DUE: February 24, 2015 at 3pm EST. PROVISIONS AND CLAUSES: The following FAR provisions and clauses apply to this acquisition: FAR 52.211-6 Brand Name or Equal. (Aug 1999) (a) If an item in this solicitation is identified as "brand name or equal," the purchase description reflects the characteristics and level of quality that will satisfy the Government's needs. The salient physical, functional, or performance characteristics that "equal" products must meet are specified in the solicitation. (b) To be considered for award, offers of "equal" products, including "equal" products of the brand name manufacturer, must- (1) Meet the salient physical, functional, or performance characteristic specified in this solicitation; (2) Clearly identify the item by- (i) Brand name, if any; and (ii) Make or model number; (3) Include descriptive literature such as illustrations, drawings, or a clear reference to previously furnished descriptive data or information available to the Contracting Officer; and (4) Clearly describe any modifications the offeror plans to make in a product to make it conform to the solicitation requirements. Mark any descriptive material to clearly show the modifications. (c) The Contracting Officer will evaluate "equal" products on the basis of information furnished by the offeror or identified in the offer and reasonably available to the Contracting Officer. The Contracting Officer is not responsible for locating or obtaining any information not identified in the offer. (d) Unless the offeror clearly indicates in its offer that the product being offered is an "equal" product, the offeror shall provide the brand name product referenced in the solicitation. 52.212-1 Instruction to Offerors Commercial Items (APR 2014); 52.212-2 Evaluation Commercial Items (OCT 2014): The purchase order will be awarded to the Lowest Price Technically Acceptable (LPTA). The award will be made on the basis of the lowest evaluated price of quotations meeting or exceeding the acceptability standards for the requirements/technical specifications stated above. The technical evaluation will be a determination based on information furnished by the vendor. The Government is not responsible for locating or securing any information which is not identified in the quote. The Government reserves the right to make an award without discussions. FAR clause 52.212-3 OFFEROR REPRESENTATIONS AND CERTIFICATIONS-COMMERCIAL ITEMS- (DEC 2014) WITH DUNS NUMBER ADDENDUM {52.204-6 (July 2013)}; FAR Clause 52.212-4 CONTRACT TERMS AND CONDITIONS - COMMERCIAL ITEMS (DEC 2014); FAR Clause 52.212-5: CONTRACT TERMS AND CONDITIONS REQUIRED TO IMPLEMENT STATUTES OR EXECUTIVE ORDERS-COMMERCIAL ITEMS (DEC 2014). The following FAR clauses cited in paragraph (b) of the clause at FAR 52.212-5 are also applicable to this acquisition; FAR Clause 52.204-10 Reporting Executive Compensation and First-Tier Subcontract Awards FAR Clause 52.209-6 Protecting the Government's Interest When Subcontracting with Contractors Debarred, Suspended, or Proposed for Debarment FAR Clause 52.219-4 Notice of Price Evaluation Preference for HUBZone Small Business Concerns. FAR Clause 52.219-6 Notice of Total Small Business Set-Aside FAR Clause 52.219-28 Post Award Small Business Program Representation FAR Clause 52.222-3 Convict Labor FAR Clause 52.222-19 Child Labor - Cooperation with Authorities and Remedies FAR Clause 52.222-21 Prohibition of Segregated Facilities FAR Clause 52.222-26 Equal Opportunity FAR Clause 52.222-36 Affirmative Action for Workers with Disabilities FAR Clause 52.223-18 Policy to Ban Text Messaging while Driving FAR Clause 52.225-3 Buy American Act-Free Trade Agreements - Israeli Trade Act Alternate I (Jan 2004) of 52.225-3 FAR Clause 52.225-13 Restrictions on Certain Foreign Purchases FAR Clause 52.232-33 Payment by Electronic Funds Transfer-System for Awards Management (SAM) Full text copies of the representations and certifications for other cited provisions and clauses may be obtained on line at the NCI website at http://ncioa.cancer.gov/oa-internet/ or from Kimesha Leake, Contract Specialist at contact@example.gov OFFERORS: Offers must be submitted on an SF-1449 with a completed 52.212-3 Offeror Representations and Certifications-Commercial Items-with DUNS Number Addendum, signed by an authorized representative of the offeror OR provide a copy of the valid certification registrations of the offeror's System for Award Management (SAM) through sam.gov. Quotations must be received in the NCI-OA contracting office by 2/24/15. Please refer to solicitation number N02RC52525-24 on all correspondence. No collect calls will be accepted. Faxed or electronic mail quotations will be accepted. All questions shall be in writing and may be addressed to the aforementioned individual noted above by February 17, 2015. No collect calls will be accepted. In order to receive an award, contractors must be registered and have valid certification in the System for Award Management through sam.gov. Primary Point of Contact: Kimesha Leake, Contract Specialist contact@example.gov phone: +1 (555) 000-0000 fax: +1 (555) 000-0000 Secondary Point of Contact: Terry Galloway, Contracting Officer contact@example.gov phone: +1 (555) 000-0000